Tonix Pharmaceuticals Holding Corp Revenue per Employee (TNXP), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tonix Pharmaceuticals Holding Corp   (NASDAQ: TNXP)
 

Tonix Pharmaceuticals Holding 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 577.88% in the second quarter 2026, year on year to cumulative value of $29 million, Tonix Pharmaceuticals Holding 's revenue per employee grew on a trailing twelve months basis to $ 204,944, this is below the company average.
Within the Healthcare sector Employees of 445 other companies have achieved higher revenue per employee. While Tonix Pharmaceuticals Holding 's total ranking has deteriorated compared to the previous quarter from 2300 to 3218. Tonix Pharmaceuticals Holding has 142 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TNXP Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 577.88 % 183.16 % 108.75 % 16.58 % -9.51 %
Sales per Employee (TTM) $ 204,944 123,634 92,303 72,528 69,232
TNXP's Total Ranking # 3218 # 2300 # 2605 # 2984 # 2397
Seq. Revenue Change 96.92 % 27.61 % 63.83 % 64.66 % -17.74 %

TNXP Company Profile >> Back to TNXP Efficiency Comparisons >> Compare TNXP Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 162
Healthcare Sector # 446
Overall Market # 3218

Revenue per Employee Statistics
High Average Low
$ 123,634 $ 83,342 $ 69,232
(Mar 31 2026)   (Jun 30 2025)



Financial Statements
Tonix Pharmaceuticals Holding 's Revenue MRQ $ 14 Millions Visit TNXP's Income Statement
Tonix Pharmaceuticals Holding 's Revenues TTM $ 29 Millions Visit TNXP's aggregate revenue growth
What are TNXP's Sales? Visit TNXP's Sales by Segment




Other Ratios
Tonix Pharmaceuticals Holding 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TNXP's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TNXP's Competitors
Revenue per Employee for TNXP's Suppliers
Revenue per Employee for TNXP's Customers

You may also want to know
TNXP's Sales Growth Rates TNXP's Pe Price to earnings ratio TNXP's Receivables Turnover Ratio TNXP's Stock Quote
TNXP's Net Income Growth Rates TNXP's Ps Price to Sales ratio TNXP's Sales per Employee TNXP's Asset Turnover Ratio
TNXP's Net Margin TNXP's Pb Price to Book ratio TNXP's Financial Strength Ratios TNXP's Dividend Payout Ratio
Date modified: 2026-09-08T22:38:38+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Interpace Biosciences Inc   358,029.41 $ 36.519  Million 102 
Protalix Biotherapeutics inc   356,721.24 $ 80.619  Million 226 
Boston Scientific Corporation  355,881.36 $ 20,997.000  Million 59,000 
Staar Surgical Co  354,848.48 $ 339.590  Million 957 
Lftd Partners Inc   353,350.13 $ 35.335  Million 100 
Strata Critical Medical Inc   352,149.75 $ 211.642  Million 601 
Opus Genetics Inc   352,000.00 $ 9.856  Million 28 
Conmed Corporation  351,706.92 $ 1,371.657  Million 3,900 
Genedx Holdings Corp   350,343.08 $ 455.446  Million 1,300 
Bio rad Laboratories Inc   347,516.78 $ 2,589.000  Million 7,450 
American Shared Hospital Services  347,241.38 $ 30.210  Million 87 
Foghorn Therapeutics Inc   346,594.34 $ 36.739  Million 106 
Coherus Oncology inc   346,503.40 $ 50.936  Million 147 
Irhythm Holdings Inc   344,042.50 $ 825.702  Million 2,400 
Maxcyte inc   341,219.78 $ 31.051  Million 91 
C4 Therapeutics Inc   336,913.46 $ 35.039  Million 104 
Omada Health Inc   336,730.35 $ 308.445  Million 916 
Cumberland Pharmaceuticals Inc   336,223.53 $ 31.269  Million 93 
Avita Medical Inc   334,650.44 $ 75.631  Million 226 
Sutro Biopharma Inc   333,591.24 $ 45.702  Million 137 
Iovance Biotherapeutics inc   333,301.54 $ 324.969  Million 975 
Gossamer Bio Inc   328,925.93 $ 53.286  Million 162 
Pacific Biosciences Of California Inc   328,484.54 $ 159.315  Million 485 
Exagen Inc   324,668.18 $ 71.427  Million 220 
Intelligent Bio Solutions Inc   324,244.23 $ 4.215  Million 13 
Quanterix Corporation  324,237.79 $ 152.716  Million 471 
Nutriband Inc   323,536.00 $ 1.618  Million 5 
Tactile Systems Technology Inc   322,577.35 $ 350.319  Million 1,086 
Ceribell Inc   311,327.22 $ 101.804  Million 327 
Bionano Genomics Inc   311,092.78 $ 30.176  Million 97 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.